Previous 10 | Next 10 |
San Francisco, California--(Newsfile Corp. - November 29, 2020) - Hagens Berman urges Precigen, Inc. (NASDAQ: PGEN) (f/k/a Intrexon) investors with significant losses to submit your losses now . A securities fraud class action has been filed and certain investors may have sufficient losses ...
San Francisco, California--(Newsfile Corp. - November 25, 2020) - Hagens Berman urges Precigen, Inc. (NASDAQ: PGEN) (f/k/a Intrexon) investors with significant losses to submit your losses now . A securities fraud class action has been filed and certain investors may have sufficient...
Precigen Announces Dosing of First Patients with UltraCAR-T® Cells Manufactured Using Proprietary UltraPorator™ System in Ongoing PRGN-3005 and PRGN-3006 Phase 1 Clinical Trials - First patients dosed with UltraPorator manufactured PRGN-3005 UltraCAR-T cells at Unive...
Miller Value Partners is a value investor. It values businesses, and not just stocks, and invests in them for the long term. During the third quarter of 2020, Miller Opportunity Equity returned 13.01% (net of fees) versus the unmanaged benchmark, the S&P 500 Index, return of 8.93%...
Precigen (PGEN): Q3 GAAP EPS of -$0.18 misses by $0.04.Revenue of $23.58M (+28.9% Y/Y) beats by $5.88M."The Precigen team has made impressive progress this quarter in driving value across our preclinical and clinical pipeline. In particular, we made several advances in our quest to meet unmet...
Precigen Reports Third Quarter 2020 and Year-to-Date Financial Results - Company to provide comprehensive clinical pipeline and data updates in early December - - Continues to advance healthcare portfolio and improve fiscal performance by executing operational efficiencies -...
Precigen to Announce Third Quarter 2020 Financial Results on November 9th: Will host Pipeline and Data Update Call in Early December PR Newswire GERMANTOWN, Md., Nov. 2, 2020 GERMANTOWN, Md. , Nov. 2, 2020 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN...
SAN FRANCISCO, CA / ACCESSWIRE / October 20, 2020 / Hagens Berman updates investors in the following publicly-traded companies and urges investors who have suffered significant losses to contact the firm. Further details about the cases can be found at the links provided. LOOP Investors Cli...
Precigen Strengthens Focus on Strategic Partnerships and Names Gaurav Vij Head of Business Development - Critical new role to advance and accelerate Precigen's growing cross-therapeutic clinical pipeline to maximize value - PR Newswire GERMANTOWN, Md., Oct. 20, 2020 ...
SAN FRANCISCO, Oct. 19, 2020 (GLOBE NEWSWIRE) -- Hagens Berman updates investors in the following publicly-traded companies and urges investors who have suffered significant losses to contact the firm. Further details about the cases can be found at the links provided. PGEN Investors ...
News, Short Squeeze, Breakout and More Instantly...
2024-06-03 14:30:04 ET Stifel Nicolaus analyst issues MARKET OUTPERFORM recommendation for PGEN on June 3, 2024 01:00PM ET. The previous analyst recommendation was Market Outperform. PGEN was trading at $1.53 at issue of the analyst recommendation. The overall analyst co...
2024-06-03 14:30:03 ET JMP Securities analyst issues UNDERPERFORM recommendation for PGEN on June 3, 2024 01:00PM ET. The previous analyst recommendation was Underperform. PGEN was trading at $1.53 at issue of the analyst recommendation. The overall analyst consensus : B...
Precigen Announces Groundbreaking Pivotal Study Data for PRGN-2012 in Patients with Recurrent Respiratory Papillomatosis in Which More than Half of Patients Achieved Complete Response PR Newswire – Phase 1/2 pivotal study met the primary safety and efficacy endpoints ...